Suppr超能文献

胸段食管鳞状细胞癌的颈部淋巴结转移不一定是不可治愈的疾病。

Cervical nodal metastasis from intrathoracic esophageal squamous cell carcinoma is not necessarily an incurable disease.

作者信息

Tong Daniel King-Hung, Kwong Dora Lai Wan, Law Simon, Wong Kam Ho, Wong John

机构信息

Department of Surgery, Li Ka Shing Faculty of Medicine, University of Hong Kong Medical Centre, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China.

出版信息

J Gastrointest Surg. 2008 Oct;12(10):1638-45; discussion 1645. doi: 10.1007/s11605-008-0654-0. Epub 2008 Aug 14.

Abstract

BACKGROUND

It remains controversial if metastatic cervical lymph nodes in patients with intrathoracic esophageal cancer signify distant metastases and are therefore incurable or if they should be regarded as regional spread with a potential for cure.

MATERIAL AND METHODS

Patients with intrathoracic esophageal squamous cell carcinoma managed from 1995 to 2007, in whom metastatic cervical lymph node spread was confirmed by fine needle aspiration cytology, were studied. Treatment strategies and outcome were reviewed.

RESULTS

There were 109 patients, of whom 98 were men. Median age was 62 years (range, 34-88). Excluding those who underwent primarily palliative treatments, there were two main groups: 22 who had upfront chemoradiation therapy and subsequent esophagectomy +/- cervical lymphadenectomy and 46 who had chemoradiation only. Significant downstaging occurred in 29 of the 68 patients (42.6%), of whom eight (11.8%) had complete pathological/clinical response. There was no mortality after esophagectomy. Median survival of patients with chemoradiation plus esophagectomy was 34.8 months compared to those with no surgery at 9.9 months, (p < 0.001). Patients with stage IV disease at presentation by virtue of nodal disease survived longer than those with the same stage because of systemic organ metastases: 9.3 vs. 3 months, (p < 0.001).

CONCLUSIONS

Prognosis of patients with metastatic cervical nodes was not uniformly dismal. Up to 20% had reasonable survival after chemoradiation and surgical resection. Stage IV disease should be revised to segregate those with nodal and systemic metastases.

摘要

背景

对于胸段食管癌患者出现的转移性颈部淋巴结,究竟是意味着远处转移因而无法治愈,还是应被视为有治愈可能的区域扩散,目前仍存在争议。

材料与方法

对1995年至2007年期间接受治疗的胸段食管鳞状细胞癌患者进行研究,这些患者经细针穿刺细胞学检查证实有转移性颈部淋巴结扩散。回顾了治疗策略及结果。

结果

共有109例患者,其中98例为男性。中位年龄为62岁(范围34 - 88岁)。排除那些主要接受姑息治疗的患者后,有两个主要组:22例患者先接受了术前放化疗,随后进行了食管切除术及±颈部淋巴结清扫术;46例患者仅接受了放化疗。68例患者中有29例(42.6%)出现显著降期,其中8例(11.8%)达到完全病理/临床缓解。食管切除术后无死亡病例。接受放化疗加食管切除术的患者中位生存期为34.8个月,而未接受手术的患者为9.9个月,(p < 0.001)。因淋巴结疾病初诊为IV期的患者比因全身器官转移处于相同分期的患者生存期更长:9.3个月对3个月,(p < 0.001)。

结论

有转移性颈部淋巴结的患者预后并非一概不佳。高达20%的患者在接受放化疗及手术切除后有合理的生存期。IV期疾病应重新分类,以区分有淋巴结转移和全身转移的患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验